1.
Noacs replace VKA as preferred oral anticoagulant among new patients
2.
COST-EFFECTIVENESS OF MONITORING ENDOXIFEN LEVELS IN BREAST CANCER PATIENTS ADJUVANTLY TREATED WITH TAMOXIFEN